Authors


Lois Levine, MA

Latest:

What You Need to Know About 3 Rare Infectious Eye Diseases

Eric D. Donnenfeld, MD, discusses 3 uncommon yet highly infectious eye diseases, emphasizing the importance of timely treatment and preventative measures.


Jelena Lewis, PharmD, BCACP

Latest:

What’s New With Non–COVID-19 Vaccines

Although COVID-19 vaccination remains the primary focus for health care, other paramount vaccines need to be recognized. Here is a review.


Marian Freedman

Latest:

Fluoroquinolone Safe for Treating Severe Refractory M Pneumoniae Pneumonia

Investigators asked the children’s parents about the history of musculoskeletal-related disease, observed the children’s gait, and performed physical examinations.


Matthew J. Grant, MD

Latest:

Barriers to Health Care Transition in Adolescents and Young Adults With Early Acquired HIV Infection

Unique challenges can affect the success of the shift from pediatric to adult care settings.


Tavell Kindall, PhD, DNP, APRN, FNP

Latest:

Multidisciplinary Perspectives on HIV Treatment

A multidisciplinary panel concludes a discussion on best practices for managing patients with HIV in various healthcare settings and overcoming social health disparities.


Tina Tan, MD

Latest:

Global Action Against AMR

Tina Tan, MD, FAAP, FIDSA, FPIDS underscores the importance of education and global collaboration in antimicrobial stewardship to tackle the escalating threat of AMR, and her takeaways from the UN General Assembly High-Level Meeting on Antimicrobial Resistance.


Lakecia Pitts, MD, MBA

Latest:

Resources Available for Patients with HIV Drug Resistance

The panel concludes its discussion by talking about resources available for providers in managing their patients with HIV who experience drug resistance.


Claudine El-Beyrouty, PharmD, BCPS

Latest:

Examining RSV Vaccines for Seniors

Two RSV vaccines for seniors were FDA approved this year and here is an overview of the vaccines and the study data.


Meghan N. Jeffres, PharmD, BCIDP

Latest:

Antimicrobial Stewardship: More Is Better

A robust stewardship program requires a comprehensive investment in technology and staff.



Samuel L. Aitken, PharmD, MPH; and Cornelius J. Clancy, MD

Latest:

IDSA Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections

Since late 2004, 7 novel antibiotics with activity against ESBL-E, CRE, and/or DTR P aeruginosa have been approved.


Itay Klaz, MD, MHCI

Latest:

5 Strategies for Improving Sepsis Care Management

Hospitalists can be better equipped to identify patients most in need of intervention and standardize sepsis management efforts.



Kimberly Humphrey, MBBS, MPH

Latest:

Climate Change Effects on Vector-Borne Disease: The Case of Lyme

With evolving weather patterns, the natural habitat of ticks is expanding, and more people are becoming susceptible to them.


Han Wei, BMED, PhD

Latest:

Backpack Science: Enabling Realtime Work in the Field for Genomic Testing of Infectious Diseases

Gathering data in the field, especially when it relates to infectious disease may have potentially profound implications for research because it enables scientists to generate valuable data quickly and efficiently without having to be in a laboratory setting.


Mandee Noval, PHARMD, BCIDP

Latest:

Stronger Than Yesterday: Decreased Hospital Readmissions After Strengthening of an OPAT Program

Although close clinician monitoring is warranted to avoid complications for this this type of treatment, it can be beneficial to patients and help reduce care costs.


Lina Meng, PharmD, BCIDP, BCCCP

Latest:

Vancomycin AUC Implementation in Resource-Limited Settings and its Associated Difficulties

The latest article from SIDP illustrates the challenges of area under the curve (AUC) implementation and offers insights for strategies and resources to overcome them.


Patricia Pecora Fulco, PharmD, BCPS, FASHP, AAHIVP

Latest:

Multidrug Resistance in a Patient With HIV

In this case study, clinicians review a challenging case.


Rodney E. Rohde, PhD, SV/SM/MB(ASCP)CM, FACSc

Latest:

From Pathogen to Infectious Disease Diagnosis: Taking on Potential Standard-of-Care Diagnostic Opportunities

In the second episode with Michael Laposata, MD, PhD, he discusses how lab professionals can communicate with infectious disease clinicians, how AI can be used in diagnostics, and potential point-of-care diagnostic opportunities for the lab.


Joy Uzoma, PharmD, BCIDP

Latest:

Penicillin and Syphilis Treatment: Sole Option or One of a Few?

Penicillin continues to be an important therapy for treating syphilis. Here is a review of the literature in comparing one of the first antibiotics to non-penicillin treatments for non-neurological syphilis.


Sylvia Ou, PharmD

Latest:

A Case of Candida Albicans Ventriculitis Secondary to E Coli Ventriculoperitoneal Shunt Infection

Rare cases of health care–associated meningitis and ventriculitis in adults caused by Candida species are associated with recent bacterial meningitis and broad-spectrum antibiotic use.


Conan MacDougall, PharmD, MAS, BCPS, BCIDP

Latest:

Children, COVID-19, and Another Crazy Respiratory Viral Season

Kevin J. Downes, MD, and Contagion® Section Editor Conan MacDougall, PharmD, MAS, BCPS, BCIDP, discuss these important topics as another season approaches.


Leslie McGorman, MPPA

Latest:

Political and Social Barriers to Ending the HIV Epidemic

Learning about these barriers is the first step to overcoming them.


Timothy Gauthier, PharmD, BCPS, BCIDP

Latest:

5 Ways Pharmacists Can Use Social Media For Professional Advancement

Social media involves information and content sharing and pharmacists can utilize the various platforms to enhance their professional needs and resources for their careers.


Christina Yen, MD

Latest:

CRAB-By No More?

Understanding the potential and limitations of new Acinetobacter baumannii active therapies.


Kevin Kavanagh, MD

Latest:

A Comparative Analysis Show Distinct Severity of COVID-19 vs Influenza

Results of a study by Yan Xie and colleagues highlight the severe impact of COVID-19, with higher death rates, increased risks of long-term complications, and greater infectivity compared to seasonal influenza.


Uzma Syed, MD, DO

Latest:

Addressing Antimicrobial Resistance in Women

Uzma Syed, MD, DO discussed how various factors increase women’s susceptibility to AMR, the importance of policies, and the need for culturally specific education and advocacy to improve health outcomes.



William Schaffner, MD

Latest:

Final Thoughts on COVID-19 and Flu

Final thoughts from experts on controlling COVID-19 and influenza.


Ryan Mynatt, PharmD, BCPS

Latest:

Tricky Infusion Issues and Potential Solutions: OPAT Edition

Outpatient parenteral antimicrobial therapy (OPAT) offers benefits for patients as well as providing cost effectiveness; however, it is not without its challenges. Two clinicians provide insights on this modality.

© 2024 MJH Life Sciences

All rights reserved.